Showing posts with label Telatinib. Show all posts
Showing posts with label Telatinib. Show all posts

Monday, June 7, 2010

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer..

Telatinib (see structure,  source : ChemBlink) :
(17-Demethoxy-17-allylaminogeldanamycin; Tanespimycin; 17-Allylaminogeldanamycin)


                  

Posted by https://www.med-chemist.com at 9:24 AM 0 comments
Labels: ,
Subscribe to: Posts (Atom)